Researchers sought to determine whether early treatment strategies would be beneficial in patients with newly diagnosed, high-risk MDS.
Posoleucel appears safe and effective for treating refractory viral infections occurring after allogeneic hematopoietic stem cell transplant.
The ONA Summit is to be held from March 17-19, 2023, as a virtual event of educational sessions targeted at oncology nurses in all roles. Attendees can earn 16 continuing education credit hours upon completion of the summit.
PTCy plus tacrolimus and MMF should be standard GVHD prophylaxis in adults who receive a well-matched PBSCT after RIC, according to researchers.
Researchers sought to verify the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in MDS.
Researchers sought to determine whether there was a relationship between methylation of the gene SLC22A3 and prognosis in different forms of AML.
The classification of acute leukemia according to WHO criteria as undifferentiated or minimally differentiated did not appear to have an effect on overall outcomes.
The recent discovery of gene mutations in a genomic study of myelodysplastic syndromes could enable diagnosis using only a blood test rather than a bone marrow biopsy.
Lenalidomide increases the risk of developing a second primary malignancy in patients with multiple myeloma, a meta-analysis suggests.
A genetic defect found on the GATA2 gene predisposes people to acute myeloid leukemia (AML) and myelodysplasia, researchers have learned.